Surface Oncology - Stock Price History | SURF

Historical daily share price chart and data for Surface Oncology since 2020 adjusted for splits. The latest closing stock price for Surface Oncology as of August 06, 2020 is 5.91.
  • The all-time high Surface Oncology stock closing price was 17.83 on July 09, 2018.
  • The Surface Oncology 52-week high stock price is 7.66, which is 29.6% above the current share price.
  • The Surface Oncology 52-week low stock price is 1.15, which is 80.5% below the current share price.
  • The average Surface Oncology stock price for the last 52 weeks is 2.85.
Surface Oncology Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 3.1640 4.3500 5.8800 1.1700 1.8800 -55.66%
2018 11.0885 13.3300 17.8300 3.6500 4.2400 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.169B $0.015B
Surface Oncology, Inc. is a clinical-stage immuno-oncology company. It develops therapies for the treatment of cancer. The company's product pipeline includes CD47, CD73, SRF231, SRF373, SRF617, SRF388 and SRF231 which are in clinical stage. Surface Oncology is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $180.670B 33.93
Medtronic (MDT) Ireland $130.133B 21.14
Stryker (SYK) United States $70.453B 27.32
Boston Scientific (BSX) United States $52.797B 31.18
Lonza Group Ag (LZAGY) Switzerland $46.625B 0.00
Baxter (BAX) United States $40.731B 24.91
Terumo (TRUMY) Japan $29.507B 37.72
ResMed (RMD) United States $29.362B 42.64
EssilorLuxottica Societe Anonyme (ESLOY) France $28.435B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.582B 22.96
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.909B 0.00
Bio-Rad Laboratories (BIO) United States $15.633B 70.78
Insulet (PODD) United States $13.583B 1345.75
Quidel (QDEL) United States $12.667B 67.10
Shandong Weigao Medical Polymer (SHWGF) China $11.849B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Canopy Growth (CGC) Canada $7.124B 0.00
Perrigo (PRGO) Ireland $7.086B 12.17
Hill-Rom Holdings (HRC) United States $6.344B 15.74
Neogen (NEOG) United States $4.261B 71.19
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.215B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.189B 0.00
Haemonetics (HAE) United States $3.859B 25.71
ICU Medical (ICUI) United States $3.850B 28.08
Envista Holdings (NVST) United States $3.668B 25.01
Abcam (ABCZY) $3.384B 0.00
Agios Pharmaceuticals (AGIO) United States $2.992B 0.00
National Vision Holdings (EYE) United States $2.723B 47.11
NuVasive (NUVA) United States $2.623B 36.55
TG Therapeutics (TGTX) United States $2.288B 0.00
AtriCure (ATRC) United States $1.912B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.878B 172.92
MacroGenics (MGNX) United States $1.468B 0.00
NanoString Technologies (NSTG) United States $1.409B 0.00
Aphria (APHA) Canada $1.385B 0.00
Aurora Cannabis (ACB) Canada $1.236B 0.00
OraSure Technologies (OSUR) United States $1.215B 0.00
Cerus (CERS) United States $1.194B 0.00
Meridian Bioscience (VIVO) United States $1.131B 42.60
Cardiovascular Systems (CSII) United States $1.084B 0.00
PetIQ (PETQ) United States $1.052B 30.39
InMode (INMD) Israel $1.034B 26.07
Quanterix (QTRX) United States $0.992B 0.00
Phibro Animal Health (PAHC) United States $0.965B 19.24
Owens & Minor (OMI) United States $0.898B 20.36
Vapotherm (VAPO) United States $0.837B 0.00
Omeros (OMER) United States $0.753B 0.00
BioLife Solutions (BLFS) United States $0.669B 190.46
Eagle Pharmaceuticals (EGRX) United States $0.668B 47.88
Surmodics (SRDX) United States $0.660B 72.36
VAREX IMAGING (VREX) United States $0.649B 16.13
Zynex (ZYXI) United States $0.629B 54.91
LeMaitre Vascular (LMAT) United States $0.591B 36.17
Lantheus Holdings (LNTH) United States $0.501B 11.67
Cytosorbents (CTSO) United States $0.417B 0.00
Viemed Healthcare (VMD) United States $0.409B 14.61
HEXO (HEXO) $0.326B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.325B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.24
InfuSystems Holdings (INFU) United States $0.254B 140.56
Organigram Holdings (OGI) Canada $0.230B 0.00
Female Health (VERU) United States $0.217B 0.00
Chimerix (CMRX) United States $0.211B 0.00
Exagen (XGN) United States $0.176B 0.00
Bovie Medical (APYX) United States $0.171B 0.00
Fonar (FONR) United States $0.161B 14.29
Wound Management Technologies (SMTI) United States $0.161B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Rockwell Medical (RMTI) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.119B 0.00
Capricor Therapeutics (CAPR) United States $0.117B 0.00
Evolus (EOLS) United States $0.112B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
MTech Acquisition (KERN) United States $0.088B 0.00
Nephros (NEPH) United States $0.074B 0.00
United-Guardian (UG) United States $0.070B 16.33
Brainsway (BWAY) Israel $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.062B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
Akers Biosciences Inc (AKER) United States $0.032B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00